Creating Digital Biomarkers with Real-World and Existing Data
XTalks
Archive
02.02.2023 1235 Bay Street Suite 802, M5R 3K4 Toronto, Canada
Conference themes
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.
Professional congress organizer (PCO)
Dryfta
Dryfta
Enquiries and Registration:
Mr. Andrew Juurinen
Pharmacology and Toxicology
Languages
English
English
Congress fees
Participation is free
Participation is free
Participants expected
150
150
Organizer contact info
Suite B2,
19702 Newark
USA
Suite B2,
19702 Newark
USA
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
